Active Ingredient History
Bevacizumab, sold under the brand name Avastin among others, is a monoclonal antibody medication used to treat a number of types of cancers and a specific eye disease. For cancer, it is given by slow injection into a vein (intravenous) and used for colon cancer, lung cancer, ovarian cancer, glioblastoma, and renal-cell carcinoma. In many of these diseases it is used as a first-line therapy. For age-related macular degeneration it is given by injection into the eye (intravitreal). Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Activated Protein C Resistance (Phase 2)
Adenocarcinoma (Phase 3)
Adenocarcinoma, Clear Cell (Phase 3)
Adenocarcinoma, Mucinous (Phase 3)
Adenocarcinoma of Lung (Phase 3)
Adenoma, Islet Cell (Phase 2/Phase 3)
Adenomatous Polyposis Coli (Phase 1)
Adenosarcoma (Phase 1)
Adnexal Diseases (Phase 2)
Adrenal Cortex (Phase 2)
Adrenocortical Carcinoma (Phase 2)
Albumin-Bound Paclitaxel (Phase 2)
Anemia (Phase 1)
Angiogenesis Modulating Agents (Phase 2)
Angioid Streaks (Phase 3)
Antineoplastic Agents (Phase 2)
Ascites (Phase 2)
Asian People (Phase 1)
Astrocytoma (Phase 2/Phase 3)
Bevacizumab (Phase 3)
Bile Duct Neoplasms (Phase 2)
Biliary Tract Neoplasms (Phase 3)
Biomarkers (Phase 2)
Blood Vessels (Phase 2)
Brain Diseases (Phase 2)
Brain Injuries (Phase 2)
Brain Neoplasms (Phase 2/Phase 3)
BRCA1 Protein (Phase 2)
Breast Carcinoma In Situ (Phase 2)
Breast Neoplasms (Phase 4)
Breast Neoplasms, Male (Phase 2)
Brenner Tumor (Phase 3)
Burkitt Lymphoma (Phase 2)
Capecitabine (Phase 2)
Carcinoid Tumor (Phase 3)
Carcinoma (Phase 3)
Carcinoma, Adenoid Cystic (Phase 2)
Carcinoma, Basal Cell (Phase 2)
Carcinoma, Hepatocellular (Phase 4)
Carcinoma, Islet Cell (Phase 2)
Carcinoma, Merkel Cell (Phase 2)
Carcinoma, Mucoepidermoid (Phase 2)
Carcinoma, Neuroendocrine (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 4)
Carcinoma, Ovarian Epithelial (Phase 4)
Carcinoma, Renal Cell (Phase 3)
Carcinoma, Squamous Cell (Phase 3)
Carcinoma, Transitional Cell (Phase 3)
Carcinoma, Verrucous (Phase 3)
Carcinosarcoma (Phase 1)
Cardiotoxicity (Phase 3)
Castleman Disease (Phase 1)
Cataract (Phase 4)
Central Nervous System Neoplasms (Phase 2)
Central Serous Chorioretinopathy (Phase 2/Phase 3)
Cholangiocarcinoma (Phase 2)
Chondrosarcoma (Phase 1)
Choriocarcinoma (Phase 2)
Choroidal Neovascularization (Phase 3)
Choroid Plexus Neoplasms (Phase 2)
Cognition Disorders (Phase 3)
Colonic Neoplasms (Phase 4)
Colorectal Neoplasms (Phase 4)
Corneal Diseases (Phase 4)
Corneal Neovascularization (Phase 4)
Coronary Artery Disease (Phase 1/Phase 2)
Coronaviridae Infections (Phase 3)
Coronavirus Infections (Phase 3)
COVID-19 (Phase 2)
Dermatology (Phase 4)
Desmoplastic Small Round Cell Tumor (Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 3)
Diabetic Neuropathies (Phase 1/Phase 2)
Diabetic Retinopathy (Phase 4)
Diffuse Intrinsic Pontine Glioma (Phase 2)
Digestive System Neoplasms (Phase 3)
Disability Evaluation (Phase 3)
Disease Attributes (Phase 2)
Disease-Free Survival (Phase 2/Phase 3)
DNA Mismatch Repair (Phase 2)
DNA Virus Infections (Phase 2)
Drug Evaluation (Phase 3)
Drugs, Investigational (Phase 3)
Drug Therapy (Phase 2)
Electroconvulsive Therapy (Phase 2)
Endocrine Gland Neoplasms (Phase 2)
Endocrine System Diseases (Phase 2)
Endometrial Neoplasms (Phase 2)
Endometriosis (Phase 1)
Endothelium (Phase 4)
Enzyme Inhibitors (Phase 2)
Ependymoma (Phase 2)
Epidermal Growth Factor (Phase 2)
Epistaxis (Phase 4)
Erdheim-Chester Disease (Phase 1)
Esophageal Diseases (Phase 2)
Esophageal Neoplasms (Phase 2/Phase 3)
Esophageal Squamous Cell Carcinoma (Phase 1/Phase 2)
Eye Diseases (Phase 4)
Fallopian Tube Neoplasms (Phase 4)
Fever (Phase 3)
Fibrosarcoma (Phase 2)
Fibrosis (Phase 4)
Gallbladder Neoplasms (Phase 3)
Ganglioglioma (Phase 1)
Ganglioneuroma (Phase 1)
Gastrinoma (Phase 2)
Gastrointestinal Neoplasms (Phase 3)
Gastrointestinal Stromal Tumors (Phase 3)
Genital Diseases, Female (Phase 3)
Genital Neoplasms, Female (Phase 2)
Geriatrics (Phase 3)
Gestational Trophoblastic Disease (Phase 2)
Glaucoma (Phase 4)
Glioblastoma (Phase 3)
Glioma (Phase 2/Phase 3)
Gliosarcoma (Phase 3)
Glucagonoma (Phase 2)
Gonadal Disorders (Phase 2)
Graft vs Host Disease (Phase 2)
Granuloma (Phase 2)
Hamartoma (Phase 3)
Head and Neck Neoplasms (Phase 2)
Healthy Volunteers (Phase 1)
Hemangioblastoma (Early Phase 1)
Hemangiosarcoma (Phase 2)
Hematologic Neoplasms (Phase 1)
Hemodialysis, Home (Early Phase 1)
Hemophilia A (Phase 4)
Hemoptysis (Phase 2)
Hemorrhage (Phase 2)
Histiocytoma (Phase 2)
Histiocytoma, Benign Fibrous (Phase 2)
HIV Infections (Phase 2)
HIV Seronegativity (Phase 2)
Hodgkin Disease (Phase 2)
Homologous Recombination (Phase 2)
Hypopharyngeal Neoplasms (Phase 2/Phase 3)
Immune Checkpoint Inhibitors (Phase 2)
Immune System Diseases (Phase 2)
Immunotherapy (Phase 3)
Infections (Phase 2)
Inflammation (Phase 3)
Inflammatory Breast Neoplasms (Phase 2/Phase 3)
Infusions, Intravenous (Phase 4)
Insulinoma (Phase 2)
Intestinal Neoplasms (Phase 3)
Intraocular Lymphoma (Phase 1)
Ischemia (Phase 4)
Keloid (Phase 2)
Kidney Failure, Chronic (Early Phase 1)
Kidney Neoplasms (Phase 3)
Laryngeal Neoplasms (Phase 2/Phase 3)
Leiomyosarcoma (Phase 3)
Leukemia (Phase 2)
Leukemia, Eosinophilic, Acute (Phase 2)
Leukemia, Hairy Cell (Phase 1)
Leukemia, Large Granular Lymphocytic (Phase 1)
Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)
Leukemia-Lymphoma, Adult T-Cell (Phase 1)
Leukemia, Monocytic, Acute (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Leukemia, Myelomonocytic, Acute (Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 1)
Liposarcoma (Phase 2)
Livedoid Vasculopathy (Phase 3)
Liver Neoplasms (Phase 4)
Liver Transplantation (Phase 2)
Lung Diseases (Phase 2)
Lung Neoplasms (Phase 3)
Lymphangioleiomyomatosis (Phase 1)
Lymphedema (Phase 1)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 3)
Lymphoma, B-Cell, Marginal Zone (Phase 1)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, Follicular (Phase 2)
Lymphoma, Large B-Cell, Diffuse (Phase 2)
Lymphoma, Large-Cell, Anaplastic (Phase 2)
Lymphoma, Large-Cell, Immunoblastic (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 1)
Lymphoma, T-Cell, Peripheral (Phase 1)
Lymphomatoid Granulomatosis (Phase 1)
Lymphoproliferative Disorders (Phase 1)
Macular Degeneration (Phase 4)
Macular Edema (Phase 4)
Male (Phase 1)
Medulloblastoma (Phase 2)
Melanoma (Phase 2)
Meninges (Phase 2)
Meningioma (Phase 2)
Meningitis (Phase 1/Phase 2)
Mesothelioma (Phase 3)
Mesothelioma, Malignant (Phase 2)
Microsatellite Instability (Phase 3)
Mouth Neoplasms (Phase 3)
Multifocal Choroiditis (Phase 3)
Multiple Myeloma (Phase 2)
Mutation (Phase 3)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Myopia (Phase 3)
Myopia, Degenerative (Phase 1)
Nasopharyngeal Carcinoma (Phase 2/Phase 3)
Nasopharyngeal Neoplasms (Phase 2)
Neoadjuvant Therapy (Phase 1/Phase 2)
Neoplasm Metastasis (Phase 4)
Neoplasm Recurrence, Local (Phase 2)
Neoplasms (Phase 4)
Neoplasms by Histologic Type (Phase 2)
Neoplasms by Site (Phase 2)
Neoplasms, Germ Cell and Embryonal (Phase 2)
Neoplasms, Glandular and Epithelial (Phase 2)
Neoplasms, Mesothelial (Phase 1)
Neoplasms, Neuroepithelial (Phase 2)
Neoplasms, Squamous Cell (Phase 2)
Neoplasms, Unknown Primary (Phase 2)
Neoplastic Syndromes, Hereditary (Phase 2/Phase 3)
Neovascularization, Pathologic (Phase 4)
Neuroblastoma (Phase 2)
Neuroectodermal Tumors (Phase 2)
Neuroendocrine Tumors (Phase 2/Phase 3)
Neurofibromatosis 1 (Phase 2)
Neurofibromatosis 2 (Phase 2)
Neurofibrosarcoma (Phase 2)
Neuroma, Acoustic (Phase 2)
Neuromyelitis Optica (Phase 1)
Neutropenia (Phase 3)
Nidovirales Infections (Phase 3)
Oligodendroglioma (Phase 2)
Oncogenes (Phase 2)
Optic Nerve Diseases (Phase 4)
Optic Nerve Glioma (Phase 1/Phase 2)
Optic Neuropathy, Ischemic (Phase 2)
Oropharyngeal Neoplasms (Phase 2/Phase 3)
Osteoporosis (Phase 3)
Osteoradionecrosis (Phase 2)
Osteosarcoma (Phase 2)
Ovarian Diseases (Phase 3)
Ovarian Neoplasms (Phase 4)
Oxaliplatin (Phase 2)
Pancreatic Neoplasms (Phase 3)
Papilloma (Phase 2)
Papilloma, Inverted (Phase 2)
Papillomavirus Infections (Phase 2)
Pathologic Processes (Phase 2)
Peritoneal Cavity (Phase 2)
Peritoneal Neoplasms (Phase 4)
Peritoneum (Phase 2)
Pharmacokinetics (Phase 1)
Pharyngeal Neoplasms (Early Phase 1)
Pinealoma (Phase 2)
Pleural Effusion, Malignant (Phase 3)
Postmenopause (Phase 2)
Postoperative Complications (Phase 3)
Premature Birth (Phase 4)
Primary Myelofibrosis (Phase 2)
Progression-Free Survival (Phase 2/Phase 3)
Prostatic Neoplasms (Phase 3)
Proto-Oncogene Proteins B-raf (Phase 2)
Pterygium (Phase 4)
Pulmonary Fibrosis (Phase 2)
Pulmonary Veno-Occlusive Disease (Phase 1/Phase 2)
Quality of Life (Phase 3)
Radiation Oncology (Phase 2)
Radiotherapy (Phase 2)
ras Proteins (Phase 2)
Rectal Neoplasms (Phase 3)
Recurrence (Phase 3)
Respiratory Distress Syndrome (Phase 2)
Respiratory Tract Diseases (Phase 3)
Respiratory Tract Infections (Phase 3)
Retina (Phase 3)
Retinal Degeneration (Phase 2)
Retinal Detachment (Phase 2)
Retinal Diseases (Phase 4)
Retinal Neovascularization (Phase 4)
Retinal Telangiectasis (Phase 3)
Retinal Vein Occlusion (Phase 4)
Retinopathy of Prematurity (Phase 4)
Rhabdoid Tumor (Phase 2)
Rhabdomyosarcoma (Phase 2)
RNA Virus Infections (Phase 3)
Salivary Gland Neoplasms (Phase 3)
Sarcoma (Phase 3)
Sarcoma, Clear Cell (Phase 2)
Sarcoma, Ewing (Phase 2)
Sarcoma, Kaposi (Phase 2)
Sarcoma, Synovial (Phase 2)
Sepsis (Phase 2)
Severe Acute Respiratory Syndrome (Phase 3)
Sezary Syndrome (Phase 1)
Small Cell Lung Carcinoma (Phase 3)
Soft Tissue Neoplasms (Phase 1)
Somatostatinoma (Phase 2)
Spinal Cord Neoplasms (Phase 2/Phase 3)
Squamous Cell Carcinoma of Head and Neck (Phase 3)
Stomach Neoplasms (Phase 4)
Survival (Phase 2)
Synovitis (Phase 4)
Telangiectasia, Hereditary Hemorrhagic (Phase 4)
Telangiectasis (Phase 3)
Testicular Neoplasms (Phase 1)
Thoracic Neoplasms (Phase 2)
Thrombosis (Phase 2)
Thymoma (Phase 2)
Thymus Neoplasms (Phase 2)
Thyroid Neoplasms (Phase 2)
Tissue Adhesions (Phase 2)
Tongue Neoplasms (Phase 3)
Trabeculectomy (Phase 2)
Triple Negative Breast Neoplasms (Phase 3)
Trophoblastic Tumor, Placental Site (Phase 2)
Tumor Virus Infections (Phase 2)
Ureteral Neoplasms (Phase 3)
Urethral Neoplasms (Phase 3)
Urinary Bladder Neoplasms (Phase 2)
Urogenital Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 3)
Uterine Neoplasms (Phase 2)
Uveitis (Phase 3)
Uveomeningoencephalitic Syndrome (Phase 3)
Vaginal Neoplasms (Phase 2)
Vascular Diseases (Phase 4)
Vascular Endothelial Growth Factor A (Phase 3)
Vestibular Diseases (Phase 2)
Vipoma (Phase 2)
Virus Diseases (Phase 3)
Vitreoretinopathy, Proliferative (Phase 2)
Vitreous Body (Phase 1)
Vitreous Hemorrhage (Phase 4)
von Hippel-Lindau Disease (Early Phase 1)
Vulvar Neoplasms (Phase 2)
Waldenstrom Macroglobulinemia (Phase 1)
Wet Macular Degeneration (Phase 3)
White Dot Syndromes (Phase 3)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
